The PROPHY-VAP Trial: Ceftriaxone to Prevent VAP in Patients with Acute Brain Injury
RebelEM
FEBRUARY 29, 2024
It is possible that the ceftriaxone altered baseline bacterial colonization within the respiratory tract, causing cultures to be negative despite positive clinical and radiological signs, leaving room for a false negative diagnosis. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury.
122 
Let's personalize your content